Cargando…
Cystoid Macular Edema: Possible Complication of Infliximab Therapy in Behçet's Disease
AIM: Infliximab, an anti-tumor necrosis factor (TNF)-α monoclonal antibody, has been reported to be effective in refractory uveoretinitis in Behçet's disease. Because it has been used clinically for a short time, information on its adverse effects is limited. We report a patient who developed c...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914443/ https://www.ncbi.nlm.nih.gov/pubmed/20737054 http://dx.doi.org/10.1159/000315489 |